Stock Analysis on Net
Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Common-Size Balance Sheet: Assets

Paying users area

Try for free

Edwards Lifesciences Corp. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Edwards Lifesciences Corp., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Cash and cash equivalents
Short-term investments
Accounts receivable, net of allowances
Other receivables
Inventories
Prepaid expenses
Other current assets
Current assets
Long-term investments
Property, plant, and equipment, net
Operating lease right-of-use assets
Goodwill
Other intangible assets, net
Deferred income taxes
Other assets
Long-term assets
Total assets

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Edwards Lifesciences Corp. current assets as a percentage of total assets decreased from 2019 to 2020 and from 2020 to 2021.
Property, plant, and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Edwards Lifesciences Corp. property, plant, and equipment, net as a percentage of total assets increased from 2019 to 2020 but then slightly decreased from 2020 to 2021.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Edwards Lifesciences Corp. long-term assets as a percentage of total assets increased from 2019 to 2020 and from 2020 to 2021.